|
Back ground. - The aim of our study is to describe the more common cardiac
manifestations of idiopathic hypereosinophilic syndrome representing the major
cause of mortality. Main points. - Current therapy consists of corticosteroid,
hydroxyurea and interferon alpha. Recent publications confirm the activity of
imatinib mesylate, a selective tyrosine kinase inhibitor, in patients with
idiopathic hypereosinophilic syndrome.
New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com CML (Chronic Myelogenous Leukemia Support List) --------------------------------- Part Of CMLHope.Com An International Community Of CML Patients For more information: http://cmlhope.com Post Message: [email protected] Subscribe: [EMAIL PROTECTED] Unsubscribe: [EMAIL PROTECTED] Change To No Mail/Web: [EMAIL PROTECTED] Change To Digest: [EMAIL PROTECTED] Change To Email: [EMAIL PROTECTED] List Help: [EMAIL PROTECTED] CML Group Web Site http://groups.yahoo.com/group/CML Yahoo! Groups Links
|
